Patents by Inventor Richard Senderoff

Richard Senderoff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATIONS FOR WOUND THERAPY
    Publication number: 20170304483
    Abstract: The present invention relates to novel formulations comprising a dry powder fibrin sealant comprised of a mixture of fibrinogen and/or thrombin, for use in the treatment of wounds or injuries, in particular for use as a topical hemostatic composition or for surgical intervention.
    Type: Application
    Filed: June 26, 2017
    Publication date: October 26, 2017
    Inventors: Eliane Schutte, Linda Zuckerman, Richard Senderoff, Glen Martyn
  • Formulations for wound therapy
    Patent number: 9717821
    Abstract: The present invention relates to novel formulations comprising a dry powder fibrin sealant comprised of a mixture of fibrinogen and/or thrombin, for use in the treatment of wounds or injuries, in particular for use as a topical hemostatic composition or for surgical intervention.
    Type: Grant
    Filed: July 6, 2012
    Date of Patent: August 1, 2017
    Assignee: Mallinckrodt Pharma IP Trading D.A.C.
    Inventors: Eliane Schutte, Linda Zuckerman, Richard Senderoff, Glen Martyn
  • Formulations for Wound Therapy
    Publication number: 20140369991
    Abstract: The present invention relates to novel formulations comprising a dry powder fibrin sealant comprised a mixture of fibrinogen and/or thrombin, for use in the treatment of wounds or injuries, in particular for use as a topical hemostatic composition or for surgical intervention.
    Type: Application
    Filed: July 6, 2012
    Publication date: December 18, 2014
    Applicant: Profibrix BV
    Inventors: Eliane Schutte, Linda Zuckerman, Richard Senderoff, Glen Martyn
  • THROMBIN COMPOSITIONS
    Publication number: 20070104705
    Abstract: Compositions comprising thrombin and methods of preparing them are disclosed. The composition may be in the form of an aqueous solution at pH 5.7-7.4 consisiting essentially of 0.1 mg/mL to 5.0 mg/mL thrombin, 2% to 4% (w/v) sucrose, 3.5% to 5% (w/v) mannitol, 50 mM to 300 mM NaCl, 0-5 mM CaCl2, 0.03% to 1% (w/v) of a surfactant or high-molecular-weight polyethylene glycol, and a physiologically acceptable buffer, or may be in lyophilized form.
    Type: Application
    Filed: October 6, 2006
    Publication date: May 10, 2007
    Inventors: Shan Jiang, Richard Senderoff, Jeffrey Meyer
  • Thrombin compositions
    Publication number: 20060002918
    Abstract: Compositions comprising thrombin and methods of preparing them are disclosed. The composition may be in the form of an aqueous solution at pH 5.7-7.4 consisiting essentially of 0.1 mg/mL to 5.0 mg/mL thrombin, 2% to 4% (w/v) sucrose, 3.5% to 5% (w/v) mannitol, 50 mM to 300 mM NaCl, 0-5 mM CaCl2, 0.03% to 1% (w/v) of a surfactant or high-molecular-weight polyethylene glycol, and a physiologically acceptable buffer, or may be in lyophilized form.
    Type: Application
    Filed: June 21, 2005
    Publication date: January 5, 2006
    Inventors: Shan Jiang, Richard Senderoff, Jeffrey Meyer